Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

MPCCC Cancer Seminars: A/Prof Yoland AntillПодробнее

MPCCC Cancer Seminars: A/Prof Yoland Antill

Expert report on neoadjuvant immune checkpoint inhibitors for MelanomaПодробнее

Expert report on neoadjuvant immune checkpoint inhibitors for Melanoma

Expert report on immune checkpoint inhibitors for dMMR Colorectal CancerПодробнее

Expert report on immune checkpoint inhibitors for dMMR Colorectal Cancer

#ESMO22 Highlights on first-line atezolizumab in NSCLC not eligible for platinum: The IPSOS studyПодробнее

#ESMO22 Highlights on first-line atezolizumab in NSCLC not eligible for platinum: The IPSOS study

Expert Video Report on featured outcomes from novel NSCLC trials @AACR 2022Подробнее

Expert Video Report on featured outcomes from novel NSCLC trials @AACR 2022

События